key: cord-0826258-0fzeypg1 authors: nan title: Predominance of Delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021 date: 2021-08-06 journal: J Infect DOI: 10.1016/j.jinf.2021.08.006 sha: 4652157d77099ed2d20e6e3bce0336a0e21fd78e doc_id: 826258 cord_uid: 0fzeypg1 nan ChAdOx1 nCoV-19 (Oxford AstraZeneca) was started in the country in January 2021, targeting healthcare workers in the first phase and later expanded to include adult population groups. 2 7 Chennai has reported more than 520,000 COVID-19 cumulative cases and 7793 deaths since the beginning of the pandemic and vaccinated around 2 million people with at least one dose of COVID-19 vaccine. 8 In this context, we described the prevalence of variants of concern (VOCs) among vaccinated and unvaccinated COVID-19 positive individuals in Chennai. Newly diagnosed COVID-19 patients are triaged in screening centres established by the Chennai Corporation. We selected three of the ten such triaging centres for the study with one centre each from the northern, central and southern parts of Chennai to ensure representativeness. We consecutively enrolled consenting COVID-19 positive individuals visiting these centres who had taken at least one dose of COVID-19 vaccine 14 days prior to confirmation of the diagnosis. We also recruited unvaccinated COVID-19 cases attending the triage centres. We collected demographic details, clinical history, comorbidities, previous COVID-19 history and date of vaccination. Nasal and oropharyngeal (N/OP) swabs and blood samples were collected from the study participants. We tested the N/OP swab samples for the detection of E and RdRP gene using Real-time Covidseq protocol (Illumina Inc, USA). 9 Amplified and purified libraries were quantified using KAPA Library Quantification Kit (Kapa Biosystems, Roche Diagnostics Corporation, USA) and loaded on NextSeq 500/550 system after normalization. Bcl files generated were analysed after conversion to fastq using CLC genomics workbench version11.0 (CLC, QIAGEN, and Germany). Reference-based mapping was performed to retrieve the sequence of the SARS-CoV-2 and analysed for phylogenetic analysis. Reference-based mapping was performed to retrieve the sequence of the SARS-CoV-2 and a phylogenetic tree was generated using MEGA software version 7. Blood samples were tested for SARS-CoV-2 IgG antibodies against S1-RBD (Siemens, Munich, Germany). (Table 1) . A neighbour joining tree was generated using Tamura-3parameter model and a boot strap of 1000 replication cycle (Figure 1 ). Phylogenetic tree revealed the presence four distinct sub-clusters in the delta variant, similar to observed seen in the larger dataset (data unpublished). Among the fully vaccinated, majority 85% (n=96) had IgG antibody against SARS-CoV-2 S1-RBD whereas 63.9% (n=154) partially vaccinated and 14.6% (n=27) in the unvaccinated group. We followed up 504 (93.5%) of the 539 participants and found that majority were symptomatic (88.5% in the fully vaccinated, 94.6% in the partially vaccinated and 94.3% in the unvaccinated). The proportion of patients with moderate/severe illness was significantly lower in the fully vaccinated group (7/104. Our study has certain limitations. We recruited majority of the vaccinated individuals visiting the triaging centre but only 5% of the unvaccinated individuals could be recruited due to logistics challenges. We could not follow up around 5% of the study participants. B.1.617.2 has the potential to infect both the vaccinated and unvaccinated individuals. However, the progression of illness seems to be prevented with vaccination. Therefore, non-pharmaceutical interventions must continue to slow down the transmission. Additionally, the pace and scale of vaccination has to be increased to mitigate the further waves of the pandemic. Systematic Genomic surveillance must be carried out to monitor the emergence of newer variants and assess their capacity to evade infection/vaccine induced immunity. Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia Ministry of Health and Family Welfare, GOI. Frequently Asked Questions Variants of Concern responsible for SARS-CoV-2 vaccine breakthrough infections from India Vaccine Breakthrough Infections with SARS-CoV-2 Variants The great escape? SARS-CoV-2 variants evading neutralizing responses Genome Sequencing by INSACOG shows variants of concern and a Novel variant in SARS-CoV-2 Seroprevalence in Tamil Nadu in State Control Room. Directorate of Public Health and Preventive Medicine Health and Family Welfare Department High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152 Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals